À propos de cet article

Citez

1. J. Y. Reginster, A. Neuprez, N. Dardenne, C. Beaudart, P. Emonts and O. Bruyère, Efficacy and safety of currently marketed anti-osteoporotic medications, Best Pract. Res. Clin. Endocrinol. Metab. 28 (2014) 809–384; https://doi.org/10.1016/j.beem.2014.09.00310.1016/j.beem.2014.09.00325432354Search in Google Scholar

2. European Medicines Agency, Protelos/Osseor to Remain Available But With Further Restrictions, London, February 2014; http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/02/WC500161971.pdf; last access date April 29, 2017.Search in Google Scholar

3. K. Mythili, S. Gayatri, K. R. Teja, K. Chitra and C. U. M. Reddy, Development and validation of RP-HPLC method for the estimation of strontium ranelate in sachet, Int. J. Pharm. Bio. Sci.2 (2011) 258–263.Search in Google Scholar

4. B. R. C. S. Reddy and N. V. B Rao, A validated stability indicating RP-HPLC method for the determination of strontium ranelate a dual acting bone agent in bulk and sachet dosage form, Rasayan J. Chem.7 (2014) 20–27.Search in Google Scholar

5. H. L. Yin and Y. J. Xu, RP-HPLC determination of strontium ranelate and its related substances, Chin. J. Pharm. Anal.2 (2009) 330–333.Search in Google Scholar

6. A. V. Gajbhar, V. P. Choudhari and B. S. Kuchekar, Development and validation of a HPTLC method for determination of strontium ranelate in the presence of its impurities, Int. J. Pharm. Bio. Sci.6 (2015) 386–394.Search in Google Scholar

7. A. S. Swami, S. A. Pishawikar and H. N. More, UV-spectrophotometric method development and validation for estimation of strontium ranelate in bulk, Int. J. Pharm. Bio. Sci.3 (2012) 171–176.Search in Google Scholar

8. M. Rizk, M. M. A. El-Alamin and M. I. Moawad, A simple kinetic spectrophotometric method for determination of strontium ranelate in bulk and pharmaceutical dosage form, Indo Am. J. Pharm. Res.5 (2015) 2503–2512; https://doi.org/10.1044/1980-iajpr.150701Search in Google Scholar

9. R. C. de Carvalho, A. D. P. Netto and F. F. de Carvalho Marques, Simultaneous determination of strontium ranelate and aspartame in pharmaceutical formulation for the treatment of postmenopausal osteoporosis by capillary zone electrophoresis, Microchem. J.117 (2014) 214–219; https://doi.org/10.1016/j.microc.2014.06.02410.1016/j.microc.2014.06.024Search in Google Scholar

10. B. V. Srinivas, U. V. Prasad, M. L. N. Acharyulua and T. S. Reddy, Determination of strontium ranelate in pure and pharmaceutical formulations by oxidimetry, Anal. Chem. Indian J.13 (2013) 205–209.Search in Google Scholar

11. M. Rizk, M. M. A. El-Alamin, H. A. M. Hendawy and M. I. Moawad, Highly sensitive differential pulse and square wave voltammetric methods for determination of strontium ranelate in bulk and pharmaceutical dosage form, Electroanalysis28 (2016) 770–777; https://doi.org/10.1002/elan.20150043710.1002/elan.201500437Search in Google Scholar

12. Z. I. Szabó, B. Székely-Szentmiklósi, B. Deák, I. Székely-Szentmiklósi, B. Kovács, K. Zöldi and E. Sipos, Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design, Acta Pharm. 66 (2016) 191–206; https://doi.org/10.1515/acph-2016-001910.1515/acph-2016-001927279063Search in Google Scholar

13. A. Gavan, A. Porfire, C. Marina and I. Tomuta, Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach, Acta Pharm. 67 (2017) 53–70; https://doi.org/10.1515/acph-2017-000910.1515/acph-2017-000928231048Search in Google Scholar

14. A. M. Kashid, D. A. Ghorpade, P. P. Toranmal and S. C. Dhawale, Development and validation of reversed phase HPLC method for the determination of vildagliptin using an experimental design, J. Anal. Chem. 70 (2015) 510–515; https://doi.org/10.1134/S106193481504006110.1134/S1061934815040061Search in Google Scholar

15. L. Kumar, M. S. Reddy, R. S. Managuli and P. K. Girish, Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles, Saudi Pharm. J.23 (2015) 549–555; https://doi.org/10.1016/j.jsps.2015.02.00110.1016/j.jsps.2015.02.001460590326594122Search in Google Scholar

16. M. Carcu-Dobrin, M. Budau, G. Hancu, L. Gagyi, A. Rusu and H. Kelemen, Enantioselective analysis of fluoxetine in pharmaceutical formulations by capillary zone electrophoresis, Saudi Pharm. J.25 (2017) 397–403; https://doi.org/10.1016/j.jsps.2016.09.00710.1016/j.jsps.2016.09.007535710328344495Search in Google Scholar

17. L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wilkström and S. Wold, Design of Experiments – Principles and Applications, 3rd ed., MKS Umetrics AB, Umeå 2008.Search in Google Scholar

18. User guide to MODDE, MKS Umetrics AB, Malmö 2014; http://umetrics.com/sites/default/files/downloads/1/user_guide_to_modde_10.1.pdf; last access date November 10, 2017.Search in Google Scholar

19. R. Peraman, K. Bhadraya and Y. P. Reddy, Analytical quality by design: a tool for regulatory flexibility and robust analytics, Int. J. Anal. Chem.2 (2015) 1–9; https://doi.org/10.1155/2015/86872710.1155/2015/868727433298625722723Search in Google Scholar

20. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Pharmaceutical Development Q8 (R2), Step 4, ICH, August 2009; https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf; last access date: February 20, 2017.Search in Google Scholar

21. P. K. Sahu, N. R. Ramisetti, T. Cecchi, S. Swain, C. S. Patro and J. Panda, An overview of experimen-tal designs in HPLC method development and validation, J. Pharm. Biomed. Anal.147 (2018) 590–611; https://doi.org/10.1016/j.jpba.2017.05.00610.1016/j.jpba.2017.05.00628579052Search in Google Scholar

22. M. Marusteri and V. Bacarea, Comparing groups for statistical differences: how to choose the right statistical test? Biochem. Med.20 (2010) 15–32; https://doi.org/10.11613/BM.2010.00410.11613/BM.2010.004Search in Google Scholar

eISSN:
1846-9558
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Pharmacy, other